Health Insurance Equity Report Card Pilot Project to Help Close the Care Gap Highlighted on World Cancer Day
PLYMOUTH, PA. CONFERENCE, Feb. 4, 2023 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®), a non-profit coalition of leading cancer centers across the nation, announces that "Each February 4th, the International Cancer At the Gap of World Cancer Day, a global awareness day organized by the Coalition for Action (UICC) by launching a new Health Equity Report Card (HERC) pilot program, this global message is about the different outcomes of cancer. Recognizing the many lives lost to cancer, improve and promote quality, effective, equitable and accessible cancer care so that all patients can live better lives. NCCN's efforts continue around the world. Today's announcement details how the HERC Pilot Program was born and what it's all about.
The effects of structural and interpersonal racism are major causes of disparities in cancer outcomes across the United States. Racial and ethnic disparities in cancer burden largely reflect longstanding inequalities in socioeconomic status and access to quality care, according to the American Cancer Society's 2023 Cancer Facts and Figures doing. People of color have experienced.
To address these issues, NCCN, ACS CAN, and NMQF launched the Elevating Cancer Equity initiative in 2020. That working group is led by Robert A. Winn, MD, and her Shonta Chambers, director of the Massey Cancer Center at Virginia Commonwealth University. MSW, Vice President of Health Equity and Community Engagement for the Patient Advocate Foundation. In early 2021, the group developed HERC to recommend actionable practice changes. If implemented, it will help providers and health care organizations identify and address discriminatory behaviors and stigma in care, address social determinants of health, and provide systemic barriers to care to overcome optimal care. helps to deal with .
The 17 actionable practice changes from HERC were refined into an implementation plan containing specific indicators, sources of evidence, and assessment methods, all reviewed by oncology administrators and providers. The first phase of a multi-phase pilot project is evaluating the potential of five major academic cancer centers to implement HERC as a tool that can measure and report on reasonable and feasible equitable care practices. increase. Include feedback from the pilot phase of implementation to ensure applicability across care settings and regions.
Robert W. Carlson, MD, CEO of NCCN. “Racial and ethnic inequalities in cancer outcomes include varying levels of access to comprehensive insurance coverage, stigma and discrimination in health care, neighborhood and built environment, and access to economic and educational opportunities. There are many factors such as the social determinants of health, food insecurity due to historical context and persistent structural discrimination. I hope that it will lead to interventions that lead to.
“Everyone diagnosed with cancer deserves the best possible care regardless of income, race, ethnicity, gender identity, disability status, sexual orientation, age or geography. ,” said Lisa Rakas, President of ACS CAN. “As we all know, ensuring equitable cancer care is critical to reducing cancer inequalities and ending cancer. It provides a tangible approach that helps
"Despite significant advances in cancer detection and treatment over the past few decades, minority communities continue to bear the heavy burden of cancer," said Gary Puckrein, president and CEO of the National Minority Quality Forum. , stated: “Injustice in cancer care is the result of failing to consider the lives of blacks, browns, yellows, reds, and the poor. If we are to fill it, we need to rethink our approach to delivery and recalibrate our systems to reduce patient risk. This tool is a step in the right direction for identifying the system changes needed to make a difference. ”
The HERC pilot program at Academic Cancer Centers is supported by a donation from AbbVie Inc. 270 Bio; Genentech; Lilly; and Sanofi Genzyme. His second pilot program at a community hospital is also in early stages, with support from GlaxoSmithKline LLC. Lilly; The Merck Foundation; A peer-reviewed article containing more information about this program will soon be published in the JNCCN - Journal of the National Comprehensive Cancer Network.
Aside from race and ethnicity in the United States, research shows that discrimination based on income, education, geographic location, and gender, sexual orientation, age, disability, and lifestyle adversely affects cancer treatment and outcomes. has been shown to have a detrimental effect on The burden of cancer in low- and medium-resource countries is particularly high, currently accounting for approximately 75% of all cancer deaths worldwide, and is expected to continue to increase.
NCCN is involved in several global endeavors to address these disparities, including the adoption of inclusive language in clinical and patient guidelines, plus ongoing collaborations in:
- Sub-Saharan Africa
- Latin America and The Caribbean
- Eastern Europe
- Middle East and North Africa (MENA)
- And Worldwide
Via National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a non-profit association of leading cancer centers dedicated to patient care, research and education. NCCN is committed to improving and promoting quality, effective, equitable and accessible cancer care so that all patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and support services. They are the recognized standard for clinical and cancer management guidelines and are the most complete and frequently updated clinical practice guidelines available in all medical disciplines. NCCN Guidelines for Patients®, supported by the NCCN Foundation®, provide professional cancer care information to inform and empower patients and caregivers. NCCN also sponsors continuing education, global initiatives, policy and research collaborations, and oncology publications. For more information, visit NCCN.org.
Via ACS CAN
The American Cancer Society's Cancer Action Network (ACS CAN) makes cancer a top priority for policymakers at all levels of government. ACS CAN works with volunteers across the country to make sure their voices are heard and that cities, states, and countries adopt evidence-based public policies that improve the lives of cancer patients and their families. We believe everyone should have a fair and equitable chance to prevent, diagnose, treat, and survive cancer. A partisan advocacy group, it has advocated for billions of dollars in cancer research funding, greater access to quality and affordable health care, and advanced tobacco control best practices. We stand with volunteers and work to change public policy and end cancer. Visit www.fightcancer.org and join the fight.
About the National Minority Quality Forum
The National Minority Quality Forum (NMQF) is a nonprofit 501(c)(3) research and advocacy organization based in Washington, DC. NMQF's mission is to reduce patient risk by providing optimal care for all. NMQF's vision is an American research, delivery, and funding system for health services whose operating principle is to reduce patient risk of treatable morbidity and mortality while improving quality of life. is. NMQF, in conjunction with the White House Cancer Moonshot Program, co-leads the Cancer Stage Shift Initiative, which moves cancer diagnosis and treatment from late-stage to early-stage to improve cancer care. , equity and underrepresented communities.
Post a Comment for "Health Insurance Equity Report Card Pilot Project to Help Close the Care Gap Highlighted on World Cancer Day"